Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Novavax, Inc. (NVAX) had Receiveable Turnover of 3.31 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$983.71M |
|
$-545.06M |
|
$343.77M |
|
$639.94M |
|
$1.55B |
|
$-566.51M |
|
$23.48M |
|
$-543.03M |
|
$-543.03M |
|
$-545.06M |
|
$-545.06M |
|
$-545.06M |
|
$-545.06M |
|
$-566.51M |
|
$-525.29M |
|
100.77M |
|
100.77M |
|
$-5.41 |
|
$-5.41 |
|
| Balance Sheet Financials | |
$1.14B |
|
$305.77M |
|
$653.60M |
|
$1.80B |
|
$1.64B |
|
$223.94M |
|
$879.28M |
|
$2.51B |
|
$-716.93M |
|
$-844.38M |
|
$-716.93M |
|
139.51M |
|
| Cash Flow Statement Financials | |
$-713.97M |
|
$-58.81M |
|
$4.47M |
|
$1.35B |
|
$583.81M |
|
$-765.03M |
|
$85.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.70 |
|
-- |
|
-- |
|
-0.45 |
|
-0.32 |
|
65.05% |
|
-57.59% |
|
-57.59% |
|
-53.40% |
|
-55.20% |
|
-55.41% |
|
$-767.74M |
|
-- |
|
-- |
|
-- |
|
0.55 |
|
8.24 |
|
|
Receiveable Turnover |
3.31 |
110.29 |
|
76.03% |
|
64.55% |
|
-30.32% |
|
110.56% |
|
$-5.14 |
|
$-7.62 |
|
$-7.09 |
|